ROBERT C. SALISBURY

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

ENZON PHARMACEUTICALS, INC.

Filing Date Source Excerpt
2006-04-12 Robert C. Salisbury, age 62, has served as a director of the Company since May 2005. ... The Finance and Audit Committee currently consists of Messrs. Salisbury (Chairman), Classon, LeBuhn and Renfro. ... The Governance and Nominating Committee currently consists of Messrs. Renfro (Chairman), Micati and Salisbury. ... During the fiscal year ended June 30, 2005, the Company recorded the following fees earned: Robert Salisbury $30,722 cash compensation ...
2007-04-10 Robert C. Salisbury, age 63, has served as a director of the Company since May 2005. ... The Finance and Audit Committee currently consists of four independent members of the Board of Directors: Salisbury (Chairman), Classon, LeBuhn and Renfro. ... The Governance and Nominating Committee currently consists of Messrs. Micati (Chairman), Renfro, LeBuhn and Salisbury. ... Director Compensation for fiscal year ended December 31, 2006: Robert Salisbury total $163,958.
2008-04-16 Robert C. Salisbury, age 64, has served as a director of the Company since May 2005... The Finance and Audit Committee currently consists of Messrs. Salisbury (Chairman), Classon, LeBuhn and Renfro... The Governance and Nominating Committee currently consists of Messrs. Micati (Chairman), Renfro, LeBuhn and Salisbury... Director compensation for fiscal year ended December 31, 2007: Robert Salisbury total $182,501.
2009-04-13 Robert C. Salisbury, has served as a director of the Company since May 2005... The Finance and Audit Committee currently consists of Messrs. Salisbury (Chairman), Classon, LeBuhn and Renfro... The Governance and Nominating Committee currently consists of Messrs. Micati (Chairman), Renfro, LeBuhn and Salisbury... Director compensation for fiscal year ended December 31, 2008: $223,897.
2010-06-10 Robert C. Salisbury has served as a director of the Company since May 2005. Mr. Salisbury also serves as a director of Asterand plc, a publicly-traded supplier of human tissue and human tissue-based research services. The Finance and Audit Committee currently consists of Mr. Salisbury (Chairman) and Messrs. Classon and LeBuhn.
2011-04-08 Robert C. Salisbury has served as a director of the Company since May 2005. In 1998, Mr. Salisbury retired from Pharmacia & Upjohn, Inc., where he had most recently served as Executive Vice President and Chief Financial Officer...Mr. Salisbury brings wide-ranging experience to the Board...The Board has nominated and recommends that the stockholders elect Robert C. Salisbury...Director...Age 67...Total Director Compensation 225,016.
2012-04-06 Robert C. Salisbury has served as a director of the Company since May 2005...Mr. Salisbury brings wide-ranging experience...DIRECTOR COMPENSATION FOR FISCAL YEAR ENDED DECEMBER 31, 2011: Robert C. Salisbury Fees Earned or Paid in Cash ($) 80,750, Stock Awards ($) 75,001, Option Awards ($) 75,003, Total ($) 230,754.

Data sourced from SEC filings. Last updated: 2025-08-30